Persistence of AR signaling in small cell neuroendocrine prostate cancer (SCNC) and intermediate atypical carcinoma (IAC): Results from the SU2C/PCF/AACR West Coast Prostate Cancer Dream Team (WCDT).
2016 ◽
Vol 34
(15_suppl)
◽
pp. 5045-5045
◽
2018 ◽
Vol 36
(15_suppl)
◽
pp. 5039-5039
2021 ◽
2019 ◽
Vol 26
(7)
◽
pp. 1667-1677
◽
2016 ◽
Vol 34
(15_suppl)
◽
pp. 5019-5019
◽
Keyword(s):
Keyword(s):
2015 ◽
Vol 33
(15_suppl)
◽
pp. 5003-5003
◽